Conmed Corp. (CNMD) Company Profile & Statistics

Conmed Corp.
CNMD
(NYSE)
Closed
71.67
+0.98 (+1.39%)
in:usd•As of: Nov 21, 2024 15:59 UTC -5
Open
71.05
High
71.83
Low
70.03

About Conmed Corp.

CEO

Curt R. Hartman

Headquarters

11311 concept boulevard

largo, fl 33773, united states

Auditor

PricewaterhouseCoopers LLP

Employees

4,000

Share Holders

447

Website

www.conmed.com

Industry

medical specialties

Sector

health technology

Company Overview

CONMED Corporation is a major medical products manufacturer specializing in surgical instruments and devices for minimally invasive procedures and monitoring. A significant portion of the company's revenues are derived from products designed for the orthopedic surgery markets of arthroscopy and powered surgical instruments. The company also sells products for general and other surgical specialties such as electrosurgery systems for all types of surgery, and endosurgery instruments for minimally invasive laparoscopic surgery. Patient Care products, including ECG electrodes for heart monitoring and pulse oximetry for blood oxygenation monitoring, are provided for various clinical settings.The company operates in two revenue segments: Orthopedic Surgery and General Surgery.

Conmed Corp. Statistics

Valuation Measures

Market Capitalization ²	2.21B
Enterprise Value	3.12B
Enterprise Value/EBITDA (ttm)	11.31
Price to Earnings Ratio (ttm)	18.49
Price to Book (mrq)	2.38
Price to Sales (ttm)	1.72
Price to Cash (ytd)	11.85

Profitability

Gross Margin (ttm)	55.65%
Operating Margin (ttm)	9.41%
Profit Margin (ttm)	10.23%
Return on Equity (ttm)	13.84%
Return on Invested Capital (ttm)	7.14%
Return on Assets (ttm)	5.26%

Income Statement

Revenue (ttm)	1.29B
Revenue Per Share (ttm)	41.70
Gross Profit (ttm)	716.86M
EBITDA (ttm)³	275.62M
Net Income Avi to Common (ttm)	131.74M
Diluted EPS (ttm)	4.21

Share Statistics

Beta (5Y Monthly)	1.45
52-Week Change	-33.49%
S&P500 52-Week Change	31.08%
S&P500 Member	No
Stock Optionable	Yes
Total Shares Outstanding ¹	30.89M
Dividend Yield	1.12%
Float ⁴	28.79M
% Held by Insiders	6.80%
% Held by Institutions	N/A

Balance Sheet

Total Cash (mrq)	38.47M
Total Cash Per Share (mrq)	1.25
Total Debt (mrq)	940.81M
Total Debt/Equity (mrq)	100.85%
Current Ratio (mrq)	2.27%
Quick Ratio (mrq)	1.06%
Book Value Per Share (mrq)	30.21

Cash Flow

Operating Cash Flow Per Share (ytd)	3.97
Free Cash Flow (ytd)	114.59M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Conmed Corp.

Trade With A Regulated Broker